Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,140.00
(
0.52%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
100.65
(
2.39%
)
Bitcoin
74,698.60
(
-0.18%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: corky post# 33448

Thursday, 08/31/2006 8:23:34 PM

Thursday, August 31, 2006 8:23:34 PM

Post# of 257253
>will [Apotex] have to pay bmy?<

Only if Apotex loses at trial next year and, even then, Apotex’s liability is limited to 50% of BMY’s lost profits rather than the 300% liability a generic company normally faces.

Other details of the Plavix case:

1. The Court ordered SNY/BMY to post a $400M bond to cover liabilities pursuant to the preliminary injunction.

2. The Plavix patent trial is now scheduled to start on 1/22/07.

http://yahoo.reuters.com/news/articlehybrid.aspx?storyID=urn:newsml:reuters.com:20060831:MTFH33654_2...

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now